Acomplia (Rimonabant) is a new weight loss drug. It is an appetite suppressant. To achieve an optimal weight loss proper medical guidance along with workouts and controlled diet program should be followed.
Acomplia is Waiting For The Test For Time in The UK and EU
Acomplia (Rimonabant) is the latest weight loss drug developed by French pharmaceutical major Sanofi-Aventis. It has been introduced in UK and EU market and is pending FDA approval for sale in US. As the drug is new the result of its effect remains to be seen.